tiprankstipranks
Medifast (MED)
NYSE:MED
US Market
Want to see MED full AI Analyst Report?

Medifast (MED) Earnings Dates, Call Summary & Reports

1,239 Followers

Earnings Data

Report Date
Aug 10, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.65
Last Year’s EPS
0.4
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 04, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call balanced clear early operational and scientific progress — notably improving coach productivity, sequential revenue stabilization, a strong cash position, cost-savings initiatives, and a defined metabolic-health product roadmap — against substantial near-term financial headwinds, including a 34% YoY revenue decline, a roughly 45% drop in active earning coaches, compressed gross margins, and continued net losses. Management is optimistic about trajectory and expects profitability improvements beginning in Q4 2026 contingent on execution and the new product rollout, but material risks remain.
Company Guidance
Medifast reconfirmed 2026 guidance of $270–$300 million in revenue and a full‑year loss per share of $1.05–$2.75, and guided Q2 revenue of $60–$80 million with loss per share of $0.50–$1.00, while expecting continued coach productivity growth in Q2 (up both year‑over‑year and sequentially), improvements toward reattaining profitability beginning in Q4 2026 after the new product launch and continuing into 2027, and working capital of more than $140 million at 12/31/2026; this outlook follows Q1 results of $76 million revenue (‑34.3% YoY), ~14,000 active earning coaches (‑44.9% YoY), average revenue per active earning coach of $5,432 (+19.2% YoY), coach productivity gains of 19% YoY and 16% sequential, gross profit $51.8 million (68.1% margin), SG&A $55.1 million, net loss $2.1 million ($0.19/sh), and $168.9 million in cash, cash equivalents and investments.
Coach Productivity Improvement
Average revenue per active earning coach rose to $5,432, a 19.2% year-over-year increase. Coach productivity increased 19% YoY and 16% sequentially — the largest YoY quarterly increase in five years and highest sequential increase in eight years. This marks the second consecutive quarter of YoY productivity gains and is cited as an early leading indicator for future revenue and coach channel growth.
Sequential Revenue Stabilization
Company reported first sequential quarterly revenue growth in three years: Q1 2026 revenue was $76.0 million versus ~$75 million in Q4 2025. Management frames this as early stabilization after multi-quarter declines.
Strong Balance Sheet and Liquidity
Cash, cash equivalents, and investments totaled $168.9 million as of 03/31/2026 with no debt. Working capital was $160.4 million, providing runway while the business executes on its turnaround.
Cost Reductions and Planned Savings
SG&A declined 35.6% YoY to $55.1 million driven by lower coach compensation ($16.2M decrease), reduced company-led marketing ($5.6M decrease), a one-time $2.2M gain on the sale of a distribution center, and lower employee compensation ($2.0M). Management expects a realignment to generate more than $30 million of future savings to help reattain profitability.
Clinical Differentiation and Product Pipeline
Company emphasized metabolic synchronization science with clinical results cited: 14% reduction in visceral fat in 16 weeks and 98% lean mass preservation over the same period. Clients working with coaches reportedly achieve up to 10x greater weight loss and 17x greater fat loss versus solo attempts. Medifast plans to launch a new comprehensive metabolic system (proprietary ingredient technology) to coaches later in the year, with a pilot showing encouraging early feedback.
Field Engagement and Referral Momentum
Field metrics show stronger engagement: improvements in the percentage of active earning coaches reaching executive director rank, acceleration in coach-led meetings, a well-attended coach incentive trip and Go Global event, and record-high share of new clients from referrals in March. Coaches participating in the referral program achieved roughly 2x higher client acquisition rates than nonparticipants.

Medifast (MED) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MED Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 10, 2026
2026 (Q2)
-0.65 / -
0.401
May 04, 2026
2026 (Q1)
-0.52 / -0.19
-0.033-475.76% (-0.16)
Feb 17, 2026
2025 (Q4)
-0.82 / -0.55
0.1-650.00% (-0.65)
Nov 03, 2025
2025 (Q3)
-0.36 / -0.21
0.35-160.00% (-0.56)
Aug 04, 2025
2025 (Q2)
-0.19 / 0.40
0.92-56.41% (-0.52)
Apr 28, 2025
2025 (Q1)
-0.25 / -0.03
0.66-105.00% (-0.69)
Feb 18, 2025
2024 (Q4)
-0.15 / 0.10
1.09-90.83% (-0.99)
Nov 04, 2024
2024 (Q3)
-0.19 / 0.35
2.12-83.49% (-1.77)
Aug 05, 2024
2024 (Q2)
0.39 / 0.92
2.77-66.79% (-1.85)
Apr 29, 2024
2024 (Q1)
0.80 / 0.66
3.67-82.02% (-3.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MED Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 04, 2026
$10.63$13.02+22.48%
Feb 17, 2026
$10.80$10.71-0.83%
Nov 03, 2025
$11.88$11.98+0.84%
Aug 04, 2025
$13.51$13.07-3.26%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medifast (MED) report earnings?
Medifast (MED) is schdueled to report earning on Aug 10, 2026, After Close (Confirmed).
    What is Medifast (MED) earnings time?
    Medifast (MED) earnings time is at Aug 10, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MED EPS forecast?
          MED EPS forecast for the fiscal quarter 2026 (Q2) is -0.65.